Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
57 participants
OBSERVATIONAL
2022-09-02
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer are:
• What is the experienced effect of gynaecological gender-affirming surgeries
Participants will be asked to fill out a questionaire pre-operatively and 3,9 and 18 months post-operatively.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
In-hospital Versus DAy Care Hysterectomy in Transgender Men
NCT05393583
Gynaecological Care for Transgender People in France in 2024.
NCT06357130
Hysterectomy for Benign Gynaecological Conditions With or Without Tubectomy
NCT02281487
Prospective Study Assessing Emotional, Sexual and Quality of Life Concerns Of Women Undergoing Removal of the Cervix Versus Removal of the Uterus,Ovaries and Fallopian Tubes For Treatment Of Early Stage Cervical Cancer
NCT00579787
Urological Complications and Management After Gynecological Operations
NCT04042129
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled to undergo gynaecological gender-affirming surgery (i.e. hysterectomy, ovariectomy, tubectomy and/or colpectomy)
Exclusion Criteria
* surgery combined with other surgeries (e.g. urethroplasty, metoidioplasty)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amsterdam UMC, location VUmc
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
J.A.F. Huirne
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amsterdam UMC, Location VU Medical Center
Amsterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020.332
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.